MIST Reports $200M Cash Runway to 2027, FDA Approves CARDAMYST Nasal Spray for PSVT, 2x Conversion vs Placebo, Launches in US Retail Pharmacies
Milestone Pharmaceuticals Inc. Common Shares · PHARMACEUTICAL PREPARATIONS · Now $1.36
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS